1,162
Views
10
CrossRef citations to date
0
Altmetric
Case Reports

Amelioration of pregnancy-associated osteoporosis after treatment with vitamin K2: a report of four patients

, , , , &
Pages 336-341 | Received 06 Mar 2012, Accepted 12 Mar 2012, Published online: 03 Jul 2012

References

  • Nordin BE, Roper A. Post-pregnancy osteoporosis; a syndrome? Lancet. 1955;268:431–4.
  • VanHouten JN, Wysolmerski JJ. Low estrogen and high parathyroid hormone-related peptide levels contribute to accerelated bone resorption and bone loss in lactating mice. Endcrinology. 2003;144:5521–9.
  • Sowers MF, Hollis BW, Shapiro B, Randolph J, Janney CA, Zhang D, Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA. 1996;276:549–54.
  • Kaur M, Pearson D, Godber I, Lawson N, Baker P, Hosking D. Longitudinal changes in bone mineral density during normal pregnancy. Bone. 2003;32:449–54.
  • Rizzoli R, Bonjour JP. Pregnancy-associated osteoporosis. Lancet. 1996;347:1274–5.
  • Dunne F, Walters B, Marshall T, Heath DA. Pregnancy associated osteoporosis. Clin Endocrinol (Oxf). 1993;39:487.
  • Yamaga A, Taga M, Takahashi T, Shirai T. A case of postpregnancy osteoporosis. Eur J Obstet Gynecol Reprod Biol. 2000;88:107–9.
  • Anai T, Tomiyasu T, Arima K, Miyakawa I. Pregnancy-associated osteoporosis with elevated levels of circulating parathyroid hormone-related protein: a report of two cases. J Obstet Gynaecol Res. 1999;25:63–7.
  • Shearer MJ. Vitamin K. Lancet. 1995;345:229–34.
  • Tabb MM, Sun A, Zhou C, Grűn F, Errandi J, Romero K, Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem. 2003;278:43919–27.
  • Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res. 2000;15:515–21.
  • Bayram S, Ozturk C, Sivrioglu K, Aydini U, Kucukoglu S. Kyphoplasty for pregnancy-associated osteoporotic vertebral fractures. Joint Bone Spine. 2006;73:564–6.
  • Bone HG, Hosking D, Devogelaer J, Tucci JR, Emkey RD, Tonino RP, Alendronate Phase III Osteoporosis Treatment Study Group. Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med. 2004;350:1189–99.
  • Shimada H, Himeno K, Michimoto T, Tanada S, Ikeuchi M, Ono Y, Prevention of vitamin K deficiency in the early period—prophylactic oral administration of VK to the mother. Nihon Sanka Fujinka Gakkai Zasshi. 1990;42:705–10; in Japanese.